Expert Review on Poliovirus Immunity and Transmission
- 15 July 2012
- journal article
- review article
- Published by Wiley in Risk Analysis
- Vol. 33 (4) , 544-605
- https://doi.org/10.1111/j.1539-6924.2012.01864.x
Abstract
Successfully managing risks to achieve wild polioviruses (WPVs) eradication and address the complexities of oral poliovirus vaccine (OPV) cessation to stop all cases of paralytic poliomyelitis depends strongly on our collective understanding of poliovirus immunity and transmission. With increased shifting from OPV to inactivated poliovirus vaccine (IPV), numerous risk management choices motivate the need to understand the tradeoffs and uncertainties and to develop models to help inform decisions. The U.S. Centers for Disease Control and Prevention hosted a meeting of international experts in April 2010 to review the available literature relevant to poliovirus immunity and transmission. This expert review evaluates 66 OPV challenge studies and other evidence to support the development of quantitative models of poliovirus transmission and potential outbreaks. This review focuses on characterization of immunity as a function of exposure history in terms of susceptibility to excretion, duration of excretion, and concentration of excreted virus. We also discuss the evidence of waning of host immunity to poliovirus transmission, the relationship between the concentration of poliovirus excreted and infectiousness, the importance of different transmission routes, and the differences in transmissibility between OPV and WPV. We discuss the limitations of the available evidence for use in polio risk models, and conclude that despite the relatively large number of studies on immunity, very limited data exist to directly support quantification of model inputs related to transmission. Given the limitations in the evidence, we identify the need for expert input to derive quantitative model inputs from the existing data.Keywords
This publication has 136 references indexed in Scilit:
- Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trialsVaccine, 2011
- Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus VaccineJournal of Virology, 2009
- Uncertainty and Sensitivity Analyses of a Decision Analytic Model for Posteradication Polio Risk ManagementRisk Analysis, 2008
- The Risks, Costs, and Benefits of Possible Future Global Policies for Managing PoliovirusesAmerican Journal of Public Health, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Preexisting Poliovirus‐Specific IgA in the Circulation Correlates with Protection against Virus Excretion in the ElderlyThe Journal of Infectious Diseases, 2008
- Combined Immunization of Infants with Oral and Inactivated Poliovirus Vaccines: Results of a Randomized Trial in The Gambia, Oman, and ThailandThe Journal of Infectious Diseases, 1997
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991
- Der Einfluß der prävakzinalen Immunität auf die Virusausscheidung und Antikörperproduktion nach Polio-Schluckimpfung mit Typ I (Sabin)*1Deutsche Medizinische Wochenschrift (1946), 1963
- Virus Excretion after Mass Vaccination with Attenuated Polioviruses in HungaryBMJ, 1961